AAAAAA
Results:
1-21
|
Results: 21
Authors:
Rodeghiero, F
Castaman, G
Citation: F. Rodeghiero et G. Castaman, Congenital von Willebrand disease type I: definition, phenotypes, clinicaland laboratory assessment, BEST P R C, 14(2), 2001, pp. 321-335
Authors:
Ruggeri, M
Tosetto, A
Castaman, G
Rodeghiero, F
Citation: M. Ruggeri et al., Pulmonary embolism after pregnancy in a patient with polycythemia Vera, AM J HEMAT, 67(3), 2001, pp. 216-217
Authors:
Castaman, G
Tosetto, A
Simioni, M
Ruggeri, M
Madeo, D
Rodeghiero, F
Citation: G. Castaman et al., Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis, THROMB HAEM, 86(3), 2001, pp. 804-808
Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep-vein thrombosis
Authors:
Ruggeri, M
Tosetto, A
Castaman, G
Rodeghiero, F
Citation: M. Ruggeri et al., Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep-vein thrombosis, LANCET, 357(9254), 2001, pp. 441-441
Authors:
Souri, M
Yee, VC
Kasai, K
Kaneshiro, T
Narasaki, K
Castaman, G
Ichinose, A
Citation: M. Souri et al., Novel Y283C mutation of the A subunit for coagulation factor XIII: molecular modelling predicts its impaired protein folding and dimer formation, BR J HAEM, 113(3), 2001, pp. 652-654
Authors:
Azzi, A
De Santis, R
Morfini, M
Zakrzewska, K
Musso, R
Santagostino, E
Castaman, G
Citation: A. Azzi et al., TT virus contaminates first-generation recombinant factor VIII concentrates, BLOOD, 98(8), 2001, pp. 2571-2573
Authors:
Ruggeri, M
Castaman, G
Tosetto, A
Rodeghiero, F
Citation: M. Ruggeri et al., Two families with combined homozygous/heterozygous factor V Leiden mutation and heterozygous G20210A factor II variant, BL COAG FIB, 11(8), 2000, pp. 783-784
Authors:
Castaman, G
Tosetto, A
Cappellari, A
Ruggeri, M
Rodeghiero, F
Citation: G. Castaman et al., The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency, BL COAG FIB, 11(4), 2000, pp. 321-326
Authors:
Tosetto, A
Castaman, G
Cappellari, A
Rodeghiero, F
Citation: A. Tosetto et al., The VITA project: Heritability of resistance to activated protein C, THROMB HAEM, 84(5), 2000, pp. 811-814
Authors:
Castaman, G
Eikenboom, JCJ
Lattuada, A
Rodeghiero, F
Citation: G. Castaman et al., Grossly abnormal proteolysis of von Willebrand factor (VWF) in a patient heterozygous for a gene deletion and mutation in the dimerization area of VWF, THROMB HAEM, 84(4), 2000, pp. 729-730
Authors:
Castaman, G
Missiaglia, E
Federici, AB
Schneppenheim, R
Rodeghiero, F
Citation: G. Castaman et al., An additional unique candidate mutation (G2470A; M7401) in the original families with von Willebrand disease type 2 M vicenza and the G3864A (R1205H)mutation, THROMB HAEM, 84(2), 2000, pp. 350-351
Authors:
Castaman, G
Eikenboom, JCJ
Contri, A
Rodeghiero, F
Citation: G. Castaman et al., Pregnancy in women with type T von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F, THROMB HAEM, 84(2), 2000, pp. 351-352
Authors:
Castaman, G
Ruggeri, M
Tosetto, A
Rodeghiero, F
Citation: G. Castaman et al., Heterogeneity of activated protein C resistance phenotype in subjects withcompound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene, THROMB HAEM, 84(2), 2000, pp. 357-358
Authors:
Schneppenheim, R
Federici, AB
Budde, U
Castaman, G
Drewke, E
Krey, S
Mannucci, PM
Riesen, G
Rodeghiero, F
Zieger, B
Zimmermann, R
Citation: R. Schneppenheim et al., Von Willebrand disease type 2M "Vicenza" in Italian and German patients: Identification of the first candidate mutation (G3864A; R1205H) in 8 families, THROMB HAEM, 83(1), 2000, pp. 136-140
Authors:
Martinelli, I
Bucciarelli, P
Margaglione, M
De Stefano, V
Castaman, G
Mannucci, PM
Citation: I. Martinelli et al., The risk of venous thromboembolism in family members with mutations in thegenes of factor V or prothrombin or both, BR J HAEM, 111(4), 2000, pp. 1223-1229
Authors:
Di Bona, E
Avvisati, G
Castaman, G
Vegna, ML
De Sanctis, V
Rodeghiero, F
Mandelli, F
Citation: E. Di Bona et al., Early haemorrhagic morbidity and mortality during remission induction withor without all-trans retinoic acid in acute promyelocytic leukaemia, BR J HAEM, 108(4), 2000, pp. 689-695
Authors:
Castaman, G
Eikenboom, JCJ
Missiaglia, E
Rodeghiero, F
Citation: G. Castaman et al., Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect, BR J HAEM, 108(4), 2000, pp. 876-879
Authors:
Castaman, G
Eikenboom, JCJ
Lattuada, A
Mannucci, PM
Rodeghiero, F
Citation: G. Castaman et al., Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutation, BR J HAEM, 108(1), 2000, pp. 188-190
Authors:
Castaman, G
Eikenboom, JCJ
Bertina, RM
Rodeghiero, F
Citation: G. Castaman et al., Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation, THROMB HAEM, 82(3), 1999, pp. 1065-1070
Authors:
Castaman, G
Tosetto, A
Ruggeri, M
Rodeghiero, F
Citation: G. Castaman et al., Pseudohomozygosity for activated protein C resistance is a risk factor forvenous thrombosis, BR J HAEM, 106(1), 1999, pp. 232-236
Authors:
Faioni, EM
Franchi, F
Bucciarelli, P
Margaglione, M
De Stefano, V
Castaman, G
Finazzi, G
Mannucci, PM
Citation: Em. Faioni et al., Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (Factor V leiden), BLOOD, 94(9), 1999, pp. 3062-3066
Risultati:
1-21
|